Tinnitus Review Finds Short-Term TMS Benefit, but Durability Is Unclear
A 2025 evidence review offers a cautious answer to whether repetitive transcranial magnetic stimulation can help chronic tinnitus: some short-term outcomes improved, but durable benefit remains unproven. The meta-analysis, published April 15 in Frontiers in Neuroscience, combined 16 randomized controlled trials involving 1,105 participants.
The results are more nuanced than either a breakthrough headline or a declaration that TMS cannot help. Different questionnaires produced different findings, and the favorable short-term signal did not translate into a demonstrated benefit at six months.
What the researchers reviewed
The analysis focused on subjective chronic tinnitus: hearing a sound without a corresponding external sound source. Researchers compared active repetitive TMS with sham stimulation across randomized studies. Sham procedures are intended to provide a comparison that helps separate the effects of stimulation from expectations and other aspects of receiving treatment.
Rather than recruiting a new group of patients, the authors pooled results from existing trials. That approach can clarify the overall pattern, but it also inherits differences among the underlying studies, including their stimulation settings, patient populations, outcome measures, and follow-up schedules.
Where the results were favorable
The review found that active TMS outperformed sham on the Tinnitus Handicap Inventory, or THI, and visual analogue scale measures. It also found a favorable short-term THI result at one month. These outcomes suggest that stimulation may reduce the reported impact or severity of tinnitus for some patients under some study conditions.
However, those findings should not be translated into a claim that the ringing disappeared. Questionnaire improvement and complete symptom elimination are different outcomes. A pooled statistical benefit also does not tell an individual patient how large or noticeable their own improvement would be.
Where the findings were less convincing
The authors did not observe a favorable long-term effect at six months. They also did not find a significant immediate effect on the Tinnitus Questionnaire and a loudness-matching measure. These mixed results are central to the interpretation, not technical details to leave out of a headline.
Tinnitus studies can measure several related but distinct experiences: perceived loudness, distress, interference with daily life, and broader symptom burden. A treatment may appear more promising on one measure than another. Readers should therefore ask exactly what improved and when it was assessed.
Why durability changes the story
A benefit measured shortly after a treatment course does not establish that it will persist. The six-month finding leaves an important question unanswered: whether any early improvement can be maintained with an acceptable treatment burden. The review does not establish a maintenance schedule that solves that problem.
It would also be too strong to conclude that no patient can experience lasting benefit. The appropriate conclusion is narrower: this pooled analysis did not demonstrate the long-term effect at that follow-up point. Lack of demonstrated benefit and proof of impossibility are not the same claim.
What the review cannot settle
Combining 16 trials does not make every TMS protocol equivalent. The authors discuss variation in stimulation targets and methods across tinnitus research. A pooled result cannot identify a single best target, pulse pattern, or treatment course unless the evidence specifically supports that comparison.
The paper's conclusion calls for larger randomized trials and more follow-up data. Future work also needs outcomes that make the clinical meaning clear. Patients need to know not only whether an average score changes, but whether an improvement is noticeable, worthwhile, and sustained.
Questions a stronger trial should answer
- Which tinnitus symptoms are most likely to improve?
- How large is the benefit compared with a convincing sham?
- Does improvement persist beyond the treatment period?
- Which protocol provides the best balance of benefit and burden?
What this means for patients
The review supports continued investigation, not a promise of a tinnitus cure. Someone considering TMS specifically for tinnitus should ask what evidence supports the exact protocol being offered, how outcomes will be measured, and what happens if an initial benefit fades.
It is also reasonable to ask about alternatives and a full tinnitus evaluation rather than assuming all tinnitus has the same cause or needs the same treatment. This meta-analysis should inform a clinical conversation; it should not replace one.
Sources
Frequently Asked Questions
- How many participants were included?
- The 2025 meta-analysis included 16 randomized controlled trials involving 1,105 people with chronic tinnitus.
- Did TMS help tinnitus in the review?
- It outperformed sham on some measures, including the Tinnitus Handicap Inventory and visual analogue scales, but findings differed by measure and follow-up time.
- Did the review show lasting benefit?
- It found a short-term benefit on the Tinnitus Handicap Inventory at one month, but did not demonstrate benefit at six months.
Written by
TMS News Editorial Team
The TMS News editorial team covers transcranial magnetic stimulation research, treatment access, and patient education, drawing on peer-reviewed studies and leading clinical centers.
PreviousMeasuring TMS Progress: Why Response and Remission Are Different
NextMotor Threshold in TMS: A Calibration Measure, Not a Depression Score
